Omi Hold Fpo (OMIDA) Quote

GM FOLKSSSS

The important thing is that you got a green checkmark, instead of the signature shit-faced (have you seen his profile pic, very appropriate) 💩🤡 emojis you got for a previous post. Good job!

🤣🤣🤣🤣🤣🤣🤣🤣🫵🤣🤣🤣🤣🤣🤣

This is what the promoter said…


If Rumpelstiltskin could choose what he was spinning, he would have picked SpiderSilk!


Breaking News: The latest KBLB news is by far the most exciting update I’ve seen from the company in the last 2 years. In fact, I belie

"Regeneron worked for 18 years to find a first partner."

How many years was it before their CEO ran away and hid from investors, failing to provide any public information?
(Actually he's still there....been there since 1988.)

No more Regeneron stories, please. Th

Good morning, hey hi, y'know.........

You're thinking that I'm talking to just myself ?......
Merely just demonstrates how stupid y'are.


.

Good Morning $RNVA

goooooooooooood morning bobber

Sounds like 100s per year to me. NiCE puts hard limits on max authorizations. What is your argument? This is the reason the UK is notorious for reimbusement and why the UK is a tiny revenue market. This is why you got to the US first if you are serious about making profit.

This is 100

In the last few years I have traveled about the country and have seen many thousands of acres of fields of solar panels. Impressive as they are, the amount of land needed for adequate implementation of solar power is summed up in your post by Mr Fukimoto
"``They don't have a lot of resources

Sheeeeeeet. No eyedia

It seems that the 1Q fins has to have all the merge info in it, so it seems a stretch to get it in by Wednesday. I suppose they could get the extension, but not sure how that plays in the grace period. If it is still there after the annual was posted, then we will know it still applies to the Q fins

MRK: Merck discontinues vibostolimab-Keytruda combination arm of Phase 3 trial
Merck announced the discontinuation of the vibostolimab and pembrolizumab coformulation arm of the Phase 3 KeyVibe-010 trial. The trial is evaluating the investigational coformulation of vibostolimab, an anti-TIGIT

Well if that's what you believe in ehy n Po t buy and flip. Follow the Make money. Leave for Goodness sake.

Never saw anyone on ihub tell so many different stories,

it's actually amazing, does he keep track of himself ? lmao

Another busy night talking to yourself

BMS finds no advantage for Opdivo + Yervoy compared to AZ’s Imfinzi in NSCLC
(GBI News)
Bristol-Myers Squibb (BMS; NYSE: BMY) last week revealed that a late-stage trial for checkpoint inhibitors Opdivo (nivolumab) and Yervoy (ipilimumab) in unresectable stage III non-small cell lung ca

Let's go guys. From 2 to 3 and beyond.

GME $20.97 •+ 20%

Boooom! $TPTW pink current baby!!!

OS has been updated from 858M to 998M.

Kelly said thank you. We had a good time with the girls, Kelly's brother and his wife and Kellys Mom and Dad at the restaurant. We actually got to see all three girls yesterday. Karolyne drove up from Tennessee Friday night for the weekend. I was so excited to see her.